|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/23 Opthea Ltd. 20-F 6/30/23 155:31M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual or Annual-Transition Report by a Foreign HTML 6.60M
Non-Canadian Issuer
3: EX-4.16 Instrument Defining the Rights of Security Holders HTML 228K
2: EX-4.5 Instrument Defining the Rights of Security Holders HTML 383K
6: EX-13.1 Annual or Quarterly Report to Security Holders HTML 45K
4: EX-12.1 Statement re: the Computation of Ratios HTML 47K
5: EX-12.2 Statement re: the Computation of Ratios HTML 47K
7: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 42K
13: R1 Document and Entity Information HTML 122K
14: R2 Consolidated Statements of Profit or Loss and HTML 107K
Other Comprehensive Income
15: R3 Consolidated Statements of Financial Position HTML 107K
16: R4 Consolidated Statements of Financial Position HTML 43K
(Parenthetical)
17: R5 Consolidated Statements of Stockholders' Equity HTML 75K
18: R6 Consolidated Statements of Stockholders' Equity HTML 47K
(Parenthetical)
19: R7 Consolidated Statements of Cash Flows HTML 87K
20: R8 Reporting Entity HTML 44K
21: R9 Basis of Accounting HTML 63K
22: R10 Summary of Accounting Policies HTML 115K
23: R11 Critical Accounting Judgments and Key Sources of HTML 70K
Estimation Uncertainty
24: R12 Application of New and Revised Accounting HTML 47K
Standards
25: R13 Segment Information HTML 48K
26: R14 Revenue HTML 67K
27: R15 Other Income HTML 67K
28: R16 Research and Development Expenses HTML 68K
29: R17 Expenses HTML 185K
30: R18 Finance Income HTML 65K
31: R19 Interest Expense on DFA HTML 65K
32: R20 Fair Value Adjustment Gain on DFA HTML 68K
33: R21 Net Foreign Exchange Loss HTML 72K
34: R22 Income Taxes HTML 242K
35: R23 Earnings per Share HTML 172K
36: R24 Current Assets - Cash and Cash Equivalents HTML 65K
37: R25 Current Assets - Receivables HTML 67K
38: R26 Current Assets - Prepayments HTML 66K
39: R27 Non-Current Assets - Right of Use Assets HTML 128K
40: R28 Non-Current Assets - Prepayments HTML 59K
41: R29 Current Liabilities - Payables HTML 64K
42: R30 Current Liabilities - Provisions HTML 62K
43: R31 Lease Liabilities HTML 101K
44: R32 Non-Current Liabilities - Financial Liabilities HTML 81K
45: R33 Non-Current Liabilities - Provisions HTML 59K
46: R34 Contributed Equity HTML 152K
47: R35 Accumulated Losses and Reserves HTML 143K
48: R36 Financial Risk Management Objectives and Policies HTML 227K
49: R37 Related Party Disclosures HTML 104K
50: R38 Commitments HTML 106K
51: R39 Contingencies HTML 48K
52: R40 Cash Flow Statements Reconciliation HTML 172K
53: R41 Key Management Personnel HTML 79K
54: R42 Share-Based Payments HTML 857K
55: R43 Events After the Balance Sheet Date HTML 54K
56: R44 Summary of Accounting Policies (Policies) HTML 142K
57: R45 Revenue (Tables) HTML 67K
58: R46 Other Income (Tables) HTML 67K
59: R47 Research and Development Expenses (Tables) HTML 67K
60: R48 Expenses (Tables) HTML 184K
61: R49 Finance Income (Tables) HTML 64K
62: R50 Interest Expense on DFA (Tables) HTML 64K
63: R51 Fair Value Adjustment Gain on DFA (Tables) HTML 64K
64: R52 Net Foreign Exchange Loss (Tables) HTML 68K
65: R53 Income Taxes (Tables) HTML 237K
66: R54 Earnings per Share (Tables) HTML 171K
67: R55 Current Assets - Cash and Cash Equivalents HTML 62K
(Tables)
68: R56 Current Assets - Receivables (Tables) HTML 67K
69: R57 Non-Current Assets - Right of Use Assets (Tables) HTML 128K
70: R58 Current Assets - Prepayments (Tables) HTML 65K
71: R59 Non-Current Assets - Prepayments (Tables) HTML 58K
72: R60 Current Liabilities - Payables (Tables) HTML 63K
73: R61 Current Liabilities - Provisions (Tables) HTML 62K
74: R62 Lease Liabilities (Tables) HTML 98K
75: R63 Non-Current Liabilities - Financial Liabilities HTML 68K
(Tables)
76: R64 Non-Current Liabilities - Provisions (Tables) HTML 58K
77: R65 Contributed Equity (Tables) HTML 124K
78: R66 Accumulated Losses and Reserves (Tables) HTML 138K
79: R67 Financial Risk Management Objectives and Policies HTML 209K
(Tables)
80: R68 Related Party Disclosures (Tables) HTML 102K
81: R69 Commitments (Tables) HTML 104K
82: R70 Cash Flow Statements Reconciliation (Tables) HTML 171K
83: R71 Key Management Personnel (Tables) HTML 77K
84: R72 Share-Based Payments (Tables) HTML 849K
85: R73 Basis of Accounting - Additional Information HTML 101K
(Details)
86: R74 Summary of Accounting Policies - Additional HTML 75K
Information (Details)
87: R75 Critical Accounting Judgements and Key Sources of HTML 66K
Estimation Uncertainty - Additional Information
(Details)
88: R76 Segment Information - Additional Information HTML 49K
(Details)
89: R77 Revenue - Summary of Revenue (Details) HTML 49K
90: R78 Other Income - Schedule of Other Income (Details) HTML 46K
91: R79 Research and Development Expenses - Summary of HTML 46K
Research and Development Expenses (Details)
92: R80 Expenses - Summary of Expenses (Details) HTML 87K
93: R81 Finance Income - Summary of Finance Income HTML 46K
(Details)
94: R82 Interest Expense on DFA - Summary of Interest HTML 46K
Expense on DFA (Details)
95: R83 Interest Expense on DFA - Additinal Information HTML 43K
(Details)
96: R84 Fair Value Adjustment Gain on DFA - Summary of HTML 43K
Fair Value Adjustment Gain on DFA (Details)
97: R85 Fair Value Adjustment Gain on DFA - Additional HTML 45K
Information (Details)
98: R86 Net Foreign Exchange Loss - Summary of Net Foreign HTML 46K
Exchange Loss (Details)
99: R87 Net Foreign Exchange Loss - Additional Information HTML 51K
(Details)
100: R88 Income Taxes - Summary of Income Tax Benefit and HTML 55K
Current Tax Receivable (Details)
101: R89 Income Taxes - Summary of Reconciliation Between HTML 59K
Income Tax Benefit and the Product of Accounting
Loss Before Income Tax Multiplied by the Group's
Applicable Income Tax Rate (Details)
102: R90 Income Taxes - Summary of Reconciliation Between HTML 44K
Income Tax Benefit and the Product of Accounting
Loss Before Income Tax Multiplied by the Group's
Applicable Income Tax Rate (Parenthetical)
(Details)
103: R91 Income Taxes - Summary of Recognized Deferred Tax HTML 67K
Assets and Liabilities in Statement of Financial
Position (Details)
104: R92 Income Taxes - Additional Information (Details) HTML 56K
105: R93 Earnings Per Share - Summary of Income Used in HTML 57K
Basic and Diluted Earnings Per Share Computation
(Details)
106: R94 Earnings Per Share - Additional Information HTML 69K
(Details)
107: R95 Earnings Per Share - Summary of Options Plans HTML 59K
(Details)
108: R96 Current Assets - Cash and Cash Equivalents - HTML 49K
Summary of Cash and Cash Equivalents (Details)
109: R97 Current Assets - Cash and Cash Equivalents - HTML 51K
Additional Information (Details)
110: R98 Current Assets - Receivables - Summary of Current HTML 52K
Assets - Receivables (Details)
111: R99 Current Assets - Receivables - Summary of Current HTML 43K
Assets - Receivables (Parenthetical) (Details)
112: R100 Current Assets - Prepayments - Summary of Current HTML 48K
Assets Prepayments (Details)
113: R101 Non-Current Assets - Prepayments - Summary of HTML 45K
Non-Current Assets - Prepayments (Details)
114: R102 Non-Current Assets - Right of Use Assets - Summary HTML 53K
of Carrying Amount of Lease (Details)
115: R103 Non-Current Assets - Right of Use Assets - HTML 43K
Additional Information (Details)
116: R104 Non-Current Assets - Right of Use Assets - Summary HTML 50K
of Lease Amounts Recognized in Profit or Loss
(Details)
117: R105 Current Liabilities - Payables - Summary of HTML 48K
Current Liabilities Payables (Details)
118: R106 Current Liabilities - Payables - Summary of HTML 43K
Current Liabilities Payables (Parenthetical)
(Details)
119: R107 Current Liabilities - Payables - Additional HTML 46K
Information (Details)
120: R108 Current Liabilities - Provisions - Summary of HTML 47K
Current Provisions (Details)
121: R109 Lease Liabilities - Additional Information HTML 46K
(Details)
122: R110 Lease Liabilities - Summary of Lease Liabilities HTML 62K
(Details)
123: R111 Non-Current Liabilities - Lease Liabilities - HTML 44K
Summary of Non-Current Liabilities - Lease
Liabilities (Details)
124: R112 Non-Current Liabilities - Financial Liabilities - HTML 49K
Summary of Noncurrent Financial Liabilities
(Details)
125: R113 Non-Current Liabilities - Financial Liabilities - HTML 69K
Additional Information (Details)
126: R114 Non-Current Liabilities - Provisions - Summary of HTML 45K
Non-Current Liabilities - Provisions (Details)
127: R115 Contributed Equity - Summary of Contributed Equity HTML 73K
(Details)
128: R116 Contributed Equity - Summary of Contributed Equity HTML 48K
(Parenthetical) (Details)
129: R117 Contributed Equity - Additional Information HTML 98K
(Details)
130: R118 Accumulated Losses and Reserves - Summary of HTML 78K
Accumulated Losses and Reserves (Details)
131: R119 Financial Risk Management Objectives and Policies HTML 57K
- Summary of Judgments of Reasonably Possible
Movements (Details)
132: R120 Financial Risk Management Objectives and Policies HTML 46K
- Summary of Judgments of Reasonably Possible
Movements (Parenthetical) (Details)
133: R121 Financial Risk Management Objectives and Policies HTML 61K
- Additional Information (Details)
134: R122 Financial Risk Management Objectives and Policies HTML 66K
- Summary of Exposure to Foreign Currency Risk
(Details)
135: R123 Related Party Disclosures - Summary of HTML 48K
Consolidated Financial Statements Include
Financial Statements of Opthea Limited and
Subsidiaries (Details)
136: R124 Related Party Disclosures - Summary of Trading HTML 49K
Transactions with Related Parties (Details)
137: R125 Related Party Disclosures - Additional Information HTML 45K
(Details)
138: R126 Commitments - Summary of Expenditure Commitments HTML 51K
Relating to Services for Clinical Trial and
Intellectual Property License Agreements (Details)
139: R127 Commitments - Additional Information (Details) HTML 48K
140: R128 Commitments - Summary of Commercial Commitments HTML 45K
(Details)
141: R129 Contingencies - Additional Information (Details) HTML 50K
142: R130 Cash Flow Statements Reconciliation - Summary of HTML 94K
Cash Flow Statements Reconciliation (Details)
143: R131 Key Management Personnel - Schedule of HTML 51K
Compensation of Key Management Personnel (Details)
144: R132 Key Management Personnel - Additional Information HTML 45K
(Details)
145: R133 Share-Based Payments - Summary of Recognized Share HTML 44K
Based Payment Expenses (Details)
146: R134 Share-Based Payments - Additional Information HTML 61K
(Details)
147: R135 Share-Based Payments - Summary of Fair Value of HTML 339K
Share Options Granted (Details)
148: R136 Share-Based Payments - Summary of Share/Rights HTML 67K
Options Outstanding (Details)
149: R137 Share-Based Payments - Summary of ADS Options HTML 74K
Outstanding (Details)
150: R138 Events After The Balance Sheet Date - Additional HTML 101K
Information (Details)
153: XML IDEA XML File -- Filing Summary XML 307K
151: XML XBRL Instance -- opt-20230630_htm XML 6.73M
152: EXCEL IDEA Workbook of Financial Report Info XLSX 255K
11: EX-101.CAL XBRL Calculations -- opt-20230630_cal XML 214K
12: EX-101.DEF XBRL Definitions -- opt-20230630_def XML 962K
10: EX-101.LAB XBRL Labels -- opt-20230630_lab XML 2.02M
8: EX-101.PRE XBRL Presentations -- opt-20230630_pre XML 1.53M
9: EX-101.SCH XBRL Schema -- opt-20230630 XSD 472K
154: JSON XBRL Instance as JSON Data -- MetaLinks 514± 811K
155: ZIP XBRL Zipped Folder -- 0000950170-23-050230-xbrl Zip 3.69M
| EX-12.1 |
Exhibit 12.1
CERTIFICATIONS
I, Megan Baldwin, certify that:
1. I have reviewed this annual report on Form 20-F of Opthea Limited;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and
5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.
Date: September 28, 2023 |
|
By: |
/s/ Megan Baldwin |
|
|
|
|
|
|
|
Principal Executive Officer |
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/28/23 | 6-K | ||
| For Period end: | 6/30/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/29/22 Opthea Ltd. 20-F 6/30/22 133:30M ActiveDisclosure/FA 2/01/22 Opthea Ltd. F-3 9:1.7M Donnelley … Solutions/FA 10/28/21 Opthea Ltd. 20-F 6/30/21 139:23M ActiveDisclosure/FA 9/13/21 Opthea Ltd. 6-K 9/13/21 4:1.1M Donnelley … Solutions/FA 10/09/20 Opthea Ltd. F-1/A 8:7M Donnelley … Solutions/FA 9/24/20 Opthea Ltd. F-1 14:9.5M Donnelley … Solutions/FA |